Congressional leaders have unveiled a second package of spending legislation to keep the government funded, with provisions included that would continue to block Washington, D.C. from legalizing marijuana sales, fund psychedelics-related clinical trials and more. House and Senate appropriations leaders released the bill on Wednesday after reaching an agreement on the remaining Fiscal Year 2024 … Continue reading Congressional Leaders Again Seek To Block D.C. Marijuana Sales, While Funding Psychedelic Studies, In New Spending Bill